BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Gastrointestinal Oncology

The World Journal of Gastrointestinal Oncology (WJGO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of gastrointestinal oncology.  It was launched on October 15, 2009 and is published monthly (12 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage gastrointestinal oncologists worldwide to submit manuscripts to the WJGO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJGO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJGO’s acceptance rate: 46%.  Submit here >>

2017 Published Issues
11 10 9 8 7 6 5 4 3 2 1
Editors-in-Chief
  • Hsin-Chen Lee, PhD, Professor, (E-mail:hclee2@ym.edu.tw)Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 112, Taiwan
  • Dimitrios H Roukos, MD, PhD, Professor, (E-mail:droukos@uoi.gr)Department of Surgery, University of Ioannina, Ioannina 45110, Greece
Indexing/Abstracting
PubMed, PubMed Central, Science Citation Index Expanded (also known as SciSearch®), and Journal Citation Reports/Science Edition.
Journal Metrics
The first impact factor of the WJGO will be issued in 2019.
ISSN
1948-5204 (online)
Retrospective Cohort Study
Paradoxical expression pattern of the epithelial mesenchymal transition-related biomarkers CD44, SLUG, N-cadherin and VSIG1/Glycoprotein A34 in gastrointestinal stromal tumors 
Attila Kövecsi, Simona Gurzu, Zoltan Szentirmay, Zsolt Kovacs, Tivadar Jr Bara, Ioan Jung 
World J Gastrointest Oncol 9(11):436-443. Published online Nov 15, 2017. doi: 10.4251/wjgo.v9.i11.436
Clinical Trials Study
Value of histomorphometric tumour thickness and smoothelin for conventional m-classification in early oesophageal adenocarcinoma 
Katharina Endhardt, Bruno Märkl, Andreas Probst, Tina Schaller, Daniela Aust 
World J Gastrointest Oncol 9(11):444-451. Published online Nov 15, 2017. doi: 10.4251/wjgo.v9.i11.444
Case Report
Gastric metastasis from ovarian adenocarcinoma presenting as a subepithelial tumor and diagnosed by endoscopic ultrasound-guided tissue acquisition 
Filippo Antonini, Liboria Laterza, Lorenzo Fuccio, Massimo Marcellini, Lucia Angelelli, Sonia Calcina, Corrado Rubini, Giampiero Macarri 
World J Gastrointest Oncol 9(11):452-456. Published online Nov 15, 2017. doi: 10.4251/wjgo.v9.i11.452